TATA-box binding protein associated factor 11 like 14 (TAF11L14)

TATA-box binding protein associated factor 11 like 14 (TAF11L14) is a predicted protein thought to enable protein heterodimerization and contribute to RNA polymerase II transcription initiation factor activity, being part of the transcription factor TFIID complex in the nucleus[1][5][6]. It is predicted to function similarly to TAF11 (a small TFIID subunit involved in assembly and function of the RNA polymerase II preinitiation complex), but TAF11L14 itself is a paralog and lacks experimentally established disease associations, known drug interactions, or defined roles as a therapeutic target[1][2][5]. Key context and details: - Is this molecule a therapeutic target? There is no evidence that TAF11L14 is the subject of drug development or established as a therapeutic target, receptor, transporter, or enzyme. - Potential issues: TAF11L14 is a predicted protein, derived as a paralog of TAF11, with biological function inferred by annotation rather than experimental validation. It is not a recognized drug target or disease biomarker. - Aliases and orthogonality: The aliases provided are synonymous and refer to the same gene/protein. - Molecular family: It belongs to the transcription machinery, specifically as a predicted component of the TFIID complex, paralleling other TBP-associated factors, but lacks direct evidence of function seen with canonical TAF11[1][2][5][6]. - Functional roles: Functions and localizations are predicted, not experimentally validated. - Disease and drug information: There are no known disease roles or interacting drugs described in existing sources. This indicates significant limitations on utility for structured drug discovery, therapeutic, or biomarker information concerning this target.

Other names

TATA-box-binding protein-associated factor 11-like protein 14TAF11L14